Skip to main content
. 2014 May-Jun;25(3):147–150. doi: 10.1155/2014/510373

TABLE 1.

Percent of invasive pneumococcal disease isolates from 2009 to 2012 in Quebec covered by pneumococcal conjugate vaccine (PCV)-13 and pneumococcal polysaccharide vaccine (PPV)-23 according to age group

PCV-13 PPV-23
Children 5 to 17 years of age (n=90) 63.3 76.7
Adults 18 to 50 years of age (n=301) 58.8 85.1
Adults ≥65 years of age (n=676) 46.6 64.5

Data presented as %